188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas, European Journal of Nuclear Medicine and Molecular Imaging, vol.112, issue.10, pp.1838-1846, 2008. ,
DOI : 10.1007/s00259-008-0735-z
URL : https://hal.archives-ouvertes.fr/inserm-00343438
Whole-animal imaging: The whole picture, Nature, vol.15, issue.7283, pp.977-980, 2010. ,
DOI : 10.1038/463977a
99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution, European Journal of Nuclear Medicine and Molecular Imaging, vol.242, issue.5, pp.602-607, 2006. ,
DOI : 10.1007/s00259-005-0007-0
Brain targeting using novel lipid nanovectors, Journal of Controlled Release, vol.126, issue.1, pp.44-49, 2008. ,
DOI : 10.1016/j.jconrel.2007.11.001
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab??? fragments, Biomaterials, vol.28, issue.33, pp.4978-4990, 2007. ,
DOI : 10.1016/j.biomaterials.2007.05.014
Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133, International Journal of Pharmaceutics, vol.423, issue.1, pp.93-101, 2012. ,
DOI : 10.1016/j.ijpharm.2011.06.001
Accumulation of sub-100??nm polymeric micelles in poorly permeable tumours depends on size, Nature Nanotechnology, vol.705, issue.12, pp.815-823, 2011. ,
DOI : 10.1038/nnano.2011.166
Targeting kidney mesangium by nanoparticles of defined size, Proceedings of the National Academy of Sciences, vol.108, issue.16, pp.6656-6661, 2011. ,
DOI : 10.1073/pnas.1103573108
Renal clearance of quantum dots, Nature Biotechnology, vol.361, issue.10, pp.1165-1170, 2007. ,
DOI : 10.1038/nbt1340
Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model, International Journal of Pharmaceutics, vol.403, issue.1-2, pp.201-206, 2011. ,
DOI : 10.1016/j.ijpharm.2010.10.015
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration, Biomaterials, vol.29, issue.12, pp.1912-1919, 2008. ,
DOI : 10.1016/j.biomaterials.2007.12.037
Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration, International Journal of Pharmaceutics, vol.331, issue.2, pp.167-175, 2007. ,
DOI : 10.1016/j.ijpharm.2006.10.029
Optical small animal imaging in the drug discovery process, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1798, issue.12, pp.2266-2273, 2010. ,
DOI : 10.1016/j.bbamem.2010.03.016
URL : https://hal.archives-ouvertes.fr/inserm-00559533
Impact of Nanotechnology on Drug Delivery, ACS Nano, vol.3, issue.1, pp.16-20, 2009. ,
DOI : 10.1021/nn900002m
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats, Molecular Cancer Therapeutics, vol.5, issue.7, pp.1710-1722, 2006. ,
DOI : 10.1158/1535-7163.MCT-06-0289
URL : https://hal.archives-ouvertes.fr/hal-00358958
Tumor targeting of functionalized lipid nanoparticles: Assessment by in vivo fluorescence imaging, European Journal of Pharmaceutics and Biopharmaceutics, vol.75, issue.2, pp.137-147, 2010. ,
DOI : 10.1016/j.ejpb.2010.02.007
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles, Biomaterials, vol.31, issue.13, pp.3657-3666, 2010. ,
DOI : 10.1016/j.biomaterials.2010.01.065
A novel phase inversionbased process for the preparation of lipid nanocarriers, Pharmaceutical Research, vol.19, issue.6, pp.875-880, 2002. ,
DOI : 10.1023/A:1016121319668
The influence of lipid nanocapsule composition on their size distribution, European Journal of Pharmaceutical Sciences, vol.18, issue.1, pp.55-61, 2003. ,
DOI : 10.1016/S0928-0987(02)00241-5
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration, European Journal of Pharmaceutics and Biopharmaceutics, vol.77, issue.3, pp.407-416, 2011. ,
DOI : 10.1016/j.ejpb.2010.12.029
Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models, Nanomedicine: Nanotechnology, Biology and Medicine, vol.9, issue.3, pp.375-387, 2013. ,
DOI : 10.1016/j.nano.2012.08.005
Passive and Active Tumour Targeting with Nanocarriers, Current Drug Discovery Technologies, vol.8, issue.3, pp.188-196, 2011. ,
DOI : 10.2174/157016311796798991
Novel Long-Circulating Lipid Nanocapsules, Pharmaceutical Research, vol.21, issue.10, pp.1783-1789, 2004. ,
DOI : 10.1023/B:PHAM.0000045229.87844.21
In vivo optical imaging of integrin ??V-??3 in mice using multivalent or monovalent cRGD targeting vectors, Molecular Cancer, vol.6, issue.1, p.41, 2007. ,
DOI : 10.1186/1476-4598-6-41
In-vivo tumor targeting of pluronic-based nano-carriers, Journal of Controlled Release, vol.147, issue.1, pp.109-117, 2010. ,
DOI : 10.1016/j.jconrel.2010.06.010
Tumor-targeted gene delivery of tumor necrosis factor-?? induces tumor necrosis and tumor regression without systemic toxicity, Cancer Gene Therapy, vol.9, issue.8, pp.673-680, 2002. ,
DOI : 10.1038/sj.cgt.7700487
Biodegradable polymeric nanoparticles based drug delivery systems, Colloids and Surfaces B: Biointerfaces, vol.75, issue.1, pp.1-18, 2010. ,
DOI : 10.1016/j.colsurfb.2009.09.001
Novel Shielded Transferrin???Polyethylene Glycol???Polyethylenimine/DNA Complexes for Systemic Tumor-Targeted Gene Transfer, Bioconjugate Chemistry, vol.14, issue.1, pp.222-231, 2002. ,
DOI : 10.1021/bc0256087
In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.143-149, 2007. ,
DOI : 10.1016/j.ijpharm.2007.06.014
URL : https://hal.archives-ouvertes.fr/inserm-00258366
Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment, International Journal of Pharmaceutics, vol.278, issue.2, pp.407-414, 2004. ,
DOI : 10.1016/j.ijpharm.2004.03.018
The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles, Molecular Pharmaceutics, vol.7, issue.4, pp.1195-1208, 2010. ,
DOI : 10.1021/mp100038h
Use of Size and a Copolymer Design Feature To Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model, ACS Nano, vol.5, issue.5, pp.4131-4144, 2011. ,
DOI : 10.1021/nn200809t
Synthesis and Characterization of the ???Sulfur-Rich??? Bis(perthiobenzoato)(dithiobenzoato)technetium(III) Heterocomplex, Inorganic Chemistry, vol.41, issue.3, pp.598-601, 2002. ,
DOI : 10.1021/ic0107577
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting, Biomaterials, vol.31, issue.2, pp.440-321, 2010. ,
DOI : 10.1016/j.biomaterials.2009.09.044
URL : https://hal.archives-ouvertes.fr/inserm-00491402
Tumor transfection after systemic injection of DNA lipid nanocapsules, Biomaterials, vol.32, issue.9, pp.2327-2333, 2011. ,
DOI : 10.1016/j.biomaterials.2010.11.063
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications, Current Drug Discovery Technologies, vol.8, issue.3, pp.207-227, 2011. ,
DOI : 10.2174/157016311796799062
Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models, Biomaterials, vol.32, issue.22, pp.5252-5261, 2011. ,
DOI : 10.1016/j.biomaterials.2011.03.076
The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability, Biomaterials, vol.31, issue.29, pp.7542-7554, 2010. ,
DOI : 10.1016/j.biomaterials.2010.06.024
Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules, Pharmaceutical Research, vol.47, issue.6, pp.1243-1250, 2006. ,
DOI : 10.1007/s11095-006-0022-2
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design, Nano Letters, vol.9, issue.5, 1909. ,
DOI : 10.1021/nl900031y
Activatable Fluorescent Probes for Tumour-Targeting Imaging in Live Mice, ChemMedChem, vol.5704, issue.10, pp.1069-1072, 2006. ,
DOI : 10.1002/cmdc.200600118
URL : https://hal.archives-ouvertes.fr/inserm-00176684
Drug development in oncology assisted by noninvasive optical imaging, International Journal of Pharmaceutics, vol.379, issue.2, pp.309-316, 2009. ,
DOI : 10.1016/j.ijpharm.2009.05.034
URL : https://hal.archives-ouvertes.fr/inserm-00390608
Tumor Accumulation of NIR Fluorescent PEG???PLA Nanoparticles: Impact of Particle Size and Human Xenograft Tumor Model, ACS Nano, vol.5, issue.11, pp.8710-8720, 2011. ,
DOI : 10.1021/nn2026353
Accumulation of nanocarriers in the ovary: A neglected toxicity risk?, Journal of Controlled Release, vol.160, issue.1, pp.105-112, 2012. ,
DOI : 10.1016/j.jconrel.2012.02.012
How Stealthy are PEG-PLA Nanoparticles? An NIR In Vivo Study Combined with Detailed Size Measurements, Pharmaceutical Research, vol.48, issue.8, pp.1995-2007, 2011. ,
DOI : 10.1007/s11095-011-0426-5
Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size, Colloids and Surfaces B: Biointerfaces, vol.66, issue.2, pp.274-280, 2008. ,
DOI : 10.1016/j.colsurfb.2008.07.004
An Assessment of the Effects of Shell Cross-Linked Nanoparticle Size, Core Composition, and Surface PEGylation on in Vivo Biodistribution, Biomacromolecules, vol.6, issue.5, pp.2541-2554, 2005. ,
DOI : 10.1021/bm050260e
Micellar Nanocarriers: Pharmaceutical Perspectives, Pharmaceutical Research, vol.277, issue.1, pp.1-16, 2007. ,
DOI : 10.1007/s11095-006-9132-0
Recent advances with liposomes as pharmaceutical carriers, Nature Reviews Drug Discovery, vol.103, issue.2, pp.145-160, 2005. ,
DOI : 10.1081/LPR-120017488
Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with 188Re-lipid nanocapsules, Biomaterials, vol.32, issue.28, pp.6781-6790, 2011. ,
DOI : 10.1016/j.biomaterials.2011.05.067
URL : https://hal.archives-ouvertes.fr/inserm-00638699
Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model, PLoS ONE, vol.359, issue.3, p.490, 2011. ,
DOI : 10.1371/journal.pone.0016926.t004
URL : https://hal.archives-ouvertes.fr/hal-00741696
Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1, Journal of Controlled Release, vol.151, issue.1, pp.74-82, 2011. ,
DOI : 10.1016/j.jconrel.2010.11.032
URL : https://hal.archives-ouvertes.fr/hal-00842655
Parameters influencing the stealthiness of colloidal drug delivery systems, Biomaterials, vol.27, issue.24, pp.4356-4373, 2006. ,
DOI : 10.1016/j.biomaterials.2006.03.039
Electrokinetic properties of noncharged lipid nanocapsules: Influence of the dipolar distribution at the interface, ELECTROPHORESIS, vol.15, issue.11, pp.2066-2075, 2005. ,
DOI : 10.1002/elps.200410145
Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles, Nanotechnology, vol.20, issue.16, 2009. ,
DOI : 10.1088/0957-4484/20/16/165101
Long-Circulating Near-Infrared Fluorescence Core-Cross-Linked Polymeric Micelles:?? Synthesis, Characterization, and Dual Nuclear/Optical Imaging, Biomacromolecules, vol.8, issue.11, pp.3422-3428, 2007. ,
DOI : 10.1021/bm7005399
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2542943
Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation, Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol.100, issue.1/2, pp.10-18, 2008. ,
DOI : 10.1002/jbm.b.31058